CRO Quality Benchmarking for Phase IV Service Providers (2017 Edition) - Research and Markets

The "CRO Quality Benchmarking - Phase IV Service Providers (9th Edition)" report has been added to Research and Markets' offering.

ISR's CRO Quality Benchmarking - Phase IV Service Providers (9th Edition) report provides pharmaceutical sponsors and service providers a Consumer Reports-style analysis of CRO quality. Respondents supplied performance ratings based on their experiences with 24 Phase IV CROs, making this report the most comprehensive assessment of CRO service quality in the industry. Now in its 9th year, this report has become a crucial tool for sponsors looking to select a Phase IV CRO and for service providers seeking an experience-based evaluation of their strengths and weaknesses.

What You Will Learn:

  • Make a more informed purchase of Phase IV services by understanding which service providers best fit your company's needs
  • Broaden your Phase IV CRO evaluation list by accessing peer-based service quality ratings across 26 critical attributes
  • Pinpoint potential delivery concerns early in a sponsor
  • CRO relationship in order to develop proactive strategies to address potential gaps

Key Topics Covered:

1. Introduction

2. Methodology

3. Respondent Demographics and Qualifications

Number of Ratings per Company

5 Major Sections

4. Service Provider Selection Process

Primary Section Takeaways

5. Service Provider Perceptions And Interactions

6. Service Provider Performance And Loyalty

Primary Section Takeaways

Rolling Average

7. Company Service Quality Profiles

Covance

ICON

INC Research

Mapi

PAREXEL

PPD

PRA

Quintiles

8. Study Data

Phase IV Leaders, Unprompted

Phase IV Leaders, Prompted

Service Provider Familiarity

Service Provider Usage

Service Provider Preference

Service Provider Differentiation

Selection Drivers: Selecting among

Preferred Providers

Preferred Provider Attributes

Gaining Importance

Selection Drivers When Not Using

Preferred Providers

Selection Drivers: No Preferred Providers

Service Provider Attributes Gaining Importance:

No Preferred Providers

Service Provider Cost Perceptions

Use of Preferred Providers

Number of Preferred Providers

9. Service Provider Drill-Downs

Accenture

Bioclinica

Chiltern

Cognizant

Covance

DaVita Clinical Research

DCRI-Duke

ICON

INC Research

inVentiv Health Clinical

Lambda

Mapi

Medpace

NAMSA

Novotech

PAREXEL

PPD

PRA

Quintiles

SGS Life Sciences

Tat a

TKL Research

UBC

Worldwide Clinical Trials

Performance Across Service Providers

10. Demographics

Company Size

Headquarters Location

Office Location

Job Title

Decision-making Responsibility

Outsourcing Involvement by Phase

Involvement in Clinical Development

Therapeutic Areas of Responsibility

Years of Industry Experience

Age

For more information about this report visit https://www.researchandmarkets.com/research/pc44zk/cro_quality

Contacts:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Pharmaceuticals

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.